Zinc in PDB 2jrj: Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B
Zinc Binding Sites:
The binding sites of Zinc atom in the Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B
(pdb code 2jrj). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B, PDB code: 2jrj:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 2jrj
Go back to
Zinc Binding Sites List in 2jrj
Zinc binding site 1 out
of 2 in the Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn62
b:0.0
occ:1.00
|
NE2
|
A:HIS41
|
2.1
|
0.0
|
1.0
|
SG
|
A:CYS44
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS17
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS20
|
2.3
|
0.0
|
1.0
|
HB
|
A:ILE19
|
2.8
|
0.0
|
1.0
|
CE1
|
A:HIS41
|
3.0
|
0.0
|
1.0
|
CD2
|
A:HIS41
|
3.1
|
0.0
|
1.0
|
HE1
|
A:HIS41
|
3.3
|
0.0
|
1.0
|
HD2
|
A:HIS41
|
3.3
|
0.0
|
1.0
|
HB2
|
A:CYS44
|
3.4
|
0.0
|
1.0
|
HB2
|
A:GLU22
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS44
|
3.5
|
0.0
|
1.0
|
HB3
|
A:CYS20
|
3.5
|
0.0
|
1.0
|
HB3
|
A:CYS17
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS20
|
3.6
|
0.0
|
1.0
|
CB
|
A:CYS17
|
3.6
|
0.0
|
1.0
|
H
|
A:CYS20
|
3.7
|
0.0
|
1.0
|
HB3
|
A:CYS44
|
3.8
|
0.0
|
1.0
|
N
|
A:CYS20
|
3.8
|
0.0
|
1.0
|
HB2
|
A:CYS17
|
3.9
|
0.0
|
1.0
|
CB
|
A:ILE19
|
3.9
|
0.0
|
1.0
|
OE2
|
A:GLU22
|
4.0
|
0.0
|
1.0
|
ND1
|
A:HIS41
|
4.1
|
0.0
|
1.0
|
CG
|
A:HIS41
|
4.2
|
0.0
|
1.0
|
C
|
A:ILE19
|
4.2
|
0.0
|
1.0
|
CA
|
A:CYS20
|
4.3
|
0.0
|
1.0
|
H
|
A:GLU22
|
4.3
|
0.0
|
1.0
|
HG3
|
A:GLU22
|
4.4
|
0.0
|
1.0
|
HB2
|
A:CYS20
|
4.4
|
0.0
|
1.0
|
HG22
|
A:ILE19
|
4.5
|
0.0
|
1.0
|
CB
|
A:GLU22
|
4.5
|
0.0
|
1.0
|
CA
|
A:ILE19
|
4.5
|
0.0
|
1.0
|
H
|
A:ILE19
|
4.6
|
0.0
|
1.0
|
CG2
|
A:ILE19
|
4.6
|
0.0
|
1.0
|
HG23
|
A:ILE19
|
4.6
|
0.0
|
1.0
|
HG12
|
A:ILE19
|
4.7
|
0.0
|
1.0
|
HG13
|
A:ILE19
|
4.7
|
0.0
|
1.0
|
CD
|
A:GLU22
|
4.7
|
0.0
|
1.0
|
H
|
A:HIS41
|
4.7
|
0.0
|
1.0
|
CG1
|
A:ILE19
|
4.7
|
0.0
|
1.0
|
CG
|
A:GLU22
|
4.7
|
0.0
|
1.0
|
N
|
A:ILE19
|
4.8
|
0.0
|
1.0
|
CA
|
A:CYS44
|
4.8
|
0.0
|
1.0
|
O
|
A:CYS17
|
4.8
|
0.0
|
1.0
|
C
|
A:CYS20
|
4.8
|
0.0
|
1.0
|
OE2
|
A:GLU47
|
4.9
|
0.0
|
1.0
|
CA
|
A:CYS17
|
4.9
|
0.0
|
1.0
|
O
|
A:ILE19
|
4.9
|
0.0
|
1.0
|
HA
|
A:CYS44
|
4.9
|
0.0
|
1.0
|
|
Zinc binding site 2 out
of 2 in 2jrj
Go back to
Zinc Binding Sites List in 2jrj
Zinc binding site 2 out
of 2 in the Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Solution Structure of the Human PIRH2 Ring-H2 Domain. Northeast Structural Genomics Consortium Target HT2B within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn63
b:0.0
occ:1.00
|
NE2
|
A:HIS38
|
2.1
|
0.0
|
1.0
|
SG
|
A:CYS58
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS55
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS36
|
2.3
|
0.0
|
1.0
|
CE1
|
A:HIS38
|
3.0
|
0.0
|
1.0
|
CD2
|
A:HIS38
|
3.1
|
0.0
|
1.0
|
HE1
|
A:HIS38
|
3.3
|
0.0
|
1.0
|
HB2
|
A:CYS55
|
3.3
|
0.0
|
1.0
|
HD2
|
A:HIS38
|
3.3
|
0.0
|
1.0
|
HB3
|
A:CYS36
|
3.3
|
0.0
|
1.0
|
HB2
|
A:CYS58
|
3.4
|
0.0
|
1.0
|
CB
|
A:CYS58
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS55
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS36
|
3.5
|
0.0
|
1.0
|
HA
|
A:CYS58
|
4.0
|
0.0
|
1.0
|
HB3
|
A:CYS55
|
4.0
|
0.0
|
1.0
|
HB2
|
A:CYS36
|
4.1
|
0.0
|
1.0
|
O
|
A:CYS36
|
4.2
|
0.0
|
1.0
|
ND1
|
A:HIS38
|
4.2
|
0.0
|
1.0
|
H
|
A:CYS58
|
4.2
|
0.0
|
1.0
|
CA
|
A:CYS58
|
4.2
|
0.0
|
1.0
|
CG
|
A:HIS38
|
4.2
|
0.0
|
1.0
|
O
|
A:CYS55
|
4.3
|
0.0
|
1.0
|
HB3
|
A:CYS58
|
4.4
|
0.0
|
1.0
|
N
|
A:CYS58
|
4.4
|
0.0
|
1.0
|
CA
|
A:CYS55
|
4.7
|
0.0
|
1.0
|
CA
|
A:CYS36
|
4.7
|
0.0
|
1.0
|
C
|
A:CYS36
|
4.8
|
0.0
|
1.0
|
H
|
A:CYS55
|
4.8
|
0.0
|
1.0
|
C
|
A:CYS55
|
4.9
|
0.0
|
1.0
|
|
Reference:
Y.Sheng,
R.C.Laister,
A.Lemak,
B.Wu,
E.Tai,
S.Duan,
J.Lukin,
M.Sunnerhagen,
S.Srisailam,
M.Karra,
S.Benchimol,
C.H.Arrowsmith.
Molecular Basis of PIRH2-Mediated P53 Ubiquitylation. Nat.Struct.Mol.Biol. V. 15 1334 2008.
ISSN: ISSN 1545-9993
PubMed: 19043414
DOI: 10.1038/NSMB.1521
Page generated: Thu Oct 17 01:20:56 2024
|